WordNet

reason or establish by induction
cause to arise; "induce a crisis" (同)bring_on
produce electric current by electrostatic or magnetic processes (同)induct
cause to do; cause to act in a specified manner; "The ads induced me to buy a VCR"; "My children finally got me to buy a computer"; "My wife made me buy a new sofa" (同)stimulate, cause, have, get, make
cause to occur rapidly; "the infection precipitated a high fever and allergic reactions" (同)stimulate, rush, hasten
use recreational drugs (同)do drugs
administer a drug to; "They drugged the kidnapped tourist" (同)dose
a substance that is used as a medicine or narcotic
brought about or caused; not spontaneous; "a case of steroid-induced weakness"

PrepTutorEJDIC

〈人〉‘に'『勧めて』(…)『させる』 / …‘を'『引き起こす』,もたらす(cause) / 〈電気〉‘を'誘導する / …‘を'帰納する
『薬』,薬品,薬剤 / 『麻薬』,麻酔剤 / 〈人〉‘に'薬(特に麻酔剤)を与える / 〈飲食物〉‘に'(麻酔薬・毒薬などの)薬を混ぜる

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 化学療法剤の腸管毒性 enterotoxicity of chemotherapeutic agents
2. 新生児における壊死性腸炎の予防 prevention of necrotizing enterocolitis in newborns
3. 好中球減少性腸炎（盲腸炎） neutropenic enterocolitis typhlitis
4. 食肉アレルギー allergy to meats
5. 金治療の主な副作用 major side effects of gold therapy

English Journal

Drug-Induced Enterocolitis Syndrome (DIES).

Novembre E1, Mori F, Barni S, Pucci N.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.Pediatr Allergy Immunol.2014 Apr 11. doi: 10.1111/pai.12225. [Epub ahead of print]
PMID 24720360

Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009.

Saito S1, Minakami H, Nakai A, Unno N, Kubo T, Yoshimura Y.Author information 1Department of Obstetrics and Gynecology, University of Toyama, Toyama, Japan.AbstractOBJECTIVE: To assess adverse fetal outcomes and short-term prognoses of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009 in Japan.
American journal of obstetrics and gynecology.Am J Obstet Gynecol.2013 Aug;209(2):130.e1-9. doi: 10.1016/j.ajog.2013.04.007. Epub 2013 Apr 9.
OBJECTIVE: To assess adverse fetal outcomes and short-term prognoses of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009 in Japan.STUDY DESIGN: Case series study. We asked the 2611 obstetric facilities in Japan that are members of the Japan Society of Obstetrics and G
PMID 23583838

Elevated rates of transaminitis during ipilimumab therapy for metastatic melanoma.

Bernardo SG1, Moskalenko M, Pan M, Shah S, Sidhu HK, Sicular S, Harcharik S, Chang R, Friedlander P, Saenger YM.Author information 1Departments of Dermatology, Mount Sinai School of Medicine, New York, New York 10029, USA.AbstractMelanoma is the deadliest form of skin cancer. Ipilimumab, a novel immunotherapy, is the first treatment shown to improve survival in patients with metastatic melanoma in large randomized controlled studies. The most concerning side effects reported in clinical studies of ipilimumab fall into the category of immune-related adverse events, which include enterocolitis, dermatitis, thyroiditis, hepatitis, hypophysitis, uveitis, and others. During the course of routine clinical care at Mount Sinai Medical Center, frequent hepatotoxicity was noted when ipilimumab was administered at a dose of 3 mg/kg according to Food and Drug Administration (FDA) guidelines. To better characterize these adverse events, we conducted a retrospective review of the first 11 patients with metastatic melanoma treated with ipilimumab at the Mount Sinai Medical Center after FDA approval. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) elevation, as defined by the National Cancer Institute's Common Terminology Criteria for Adverse Events, each occurred in six of 11 cases (≥grade 1), a notably higher frequency than could be expected on the basis of the FDA licensing study where elevations were reported in 0.8 and 1.5% of patients for AST and ALT, respectively. Grade 3 elevations in AST occurred in three of 11 patients as compared with 0% in the licensing trial. All cases of transaminitis resolved when ipilimumab was temporarily withheld without administration of immunosuppressive medication. During routine clinical care of late-stage melanoma patients with ipilimumab, physicians should monitor patients closely for hepatotoxicity and be aware that toxicity rates may differ across populations during ipilimumab therapy.
Melanoma research.Melanoma Res.2013 Feb;23(1):47-54. doi: 10.1097/CMR.0b013e32835c7e68.
Melanoma is the deadliest form of skin cancer. Ipilimumab, a novel immunotherapy, is the first treatment shown to improve survival in patients with metastatic melanoma in large randomized controlled studies. The most concerning side effects reported in clinical studies of ipilimumab fall into the ca
PMID 23262440